Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Gastrointestinal Tolerability”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Looking for participantsNCT07481383
What this trial is testing

A First-in-Human Study to Evaluate Implantable Iontophoresis Chemotherapy Delivery Device With Gemcitabine Once Weekly or Twice Weekly in Participants With Pancreatic Cancer

Who this might be right for
Pancreatic Adenocarcinoma Non-resectable
Continuity Biosciences, LLC 12
Testing effectiveness (Phase 2)Study completedNCT05638737
What this trial is testing

A Study in Participants With Non-cirrhotic NASH With Fibrosis

Who this might be right for
Non-Cirrhotic Non-alcoholic Steatohepatitis With Fibrosis
AstraZeneca 112
Early research (Phase 1)UnknownNCT04801095
What this trial is testing

A Phase I Study of WM-S1-030 in Patients With Advanced Solid Tumors

Who this might be right for
Advanced Solid TumorMetastatic Solid TumorColorectal Cancer+4 more
Wellmarker Bio 100
Early research (Phase 1)Looking for participantsNCT06773312
What this trial is testing

BC001 in Combination with Sintilimab and XELOX in the Treatment of HER-2 Negative Advanced or Metastatic Gastric Cancer or Gastroesophageal Junction Adenocarcinoma.

Who this might be right for
Advanced or Metastatic Gastric CancerGastroesophageal Junction Adenocarcinoma
Sichuan Luzhou Buchang Biopharmaceutical Co., Ltd. 80
Early research (Phase 1)UnknownNCT05155657
What this trial is testing

Study of Decompensated Alcoholic Cirrhosis Treatment by Stem Cells

Who this might be right for
Alcoholic Cirrhosis
Yantai Yuhuangding Hospital 36
Not applicableWithdrawnNCT04775056
What this trial is testing

Evaluate Vaccines Against COVID-19 in the Real World

Who this might be right for
Chronic Liver DiseaseHepatic Carcinoma
Humanity & Health Medical Group Limited
Early research (Phase 1)Study completedNCT01486329
What this trial is testing

VXM01 Phase I Dose Escalation Study in Patients With Locally Advanced, Inoperable and Stage IV Pancreatic Cancer

Who this might be right for
Stage IV Pancreatic Cancer
Vaximm GmbH 72
Early research (Phase 1)Looking for participantsNCT07431112
What this trial is testing

AIR-001 in Adults With Alpha-1 Antitrypsin Deficiency (AATD)

Who this might be right for
Alpha 1 Antitrypsin Deficiency
AIRNA Corporation 54
Testing effectiveness (Phase 2)Study completedNCT00861809
What this trial is testing

The Effect of Single Doses of the Motilin Receptor Agonist GSK962040 in Type I Diabetic Patients With Gastroparesis

Who this might be right for
Gastroparesis
GlaxoSmithKline 11
Early research (Phase 1)Study completedNCT03362242
What this trial is testing

Study of ARO-AAT in Normal Adult Volunteers

Who this might be right for
Alpha 1-Antitrypsin Deficiency
Arrowhead Pharmaceuticals 45
Testing effectiveness (Phase 2)Ended earlyNCT05497453
What this trial is testing

Evaluate OTX-2002 in Patients with Hepatocellular Carcinoma and Other Solid Tumor Types Known for Association with the MYC Oncogene

Who this might be right for
Hepatocellular CarcinomaSolid TumorHepatocellular Carcinoma Non-resectable+4 more
Omega Therapeutics 24
Early research (Phase 1)Study completedNCT05770895
What this trial is testing

Study of HBV Therapeutic Vaccines GS-2829 and GS-6779 in Healthy Participants and Participants With Chronic Hepatitis B

Who this might be right for
Chronic Hepatitis B
Gilead Sciences 83
Not applicableNot Yet RecruitingNCT07342972
What this trial is testing

Gastrointestinal Symptoms and Tolerance in Infants Fed Goat or Cow's Milk-based Infant Formula

Who this might be right for
Gastrointestinal ToleranceGastrointestinal SymptomsInfections+2 more
Ausnutria Hyproca B.V. 144
Testing effectiveness (Phase 2)Study completedNCT01534637
What this trial is testing

Aprepitant in Preventing Nausea and Vomiting in Patients Undergoing Chemotherapy and Radiation Therapy for Pancreatic Cancer

Who this might be right for
Extrahepatic Bile Duct CancerNauseaVomiting+3 more
Wake Forest University Health Sciences 22
Early research (Phase 1)Study completedNCT00426712
What this trial is testing

Safety of HEPLISAV™ Hepatitis B Virus Vaccine in End-stage Kidney Failure Patients

Who this might be right for
Hepatitis B
Dynavax Technologies Corporation 42
Early research (Phase 1)UnknownNCT05783570
What this trial is testing

To Evaluate the Safety, Tolerability and Preliminary Efficacy of EU307

Who this might be right for
Advanced Hepatocellular Carcinoma
Eutilex 12
Early research (Phase 1)UnknownNCT05536427
What this trial is testing

Safety and Efficacy of IPM001 in Patients With Advanced Hepatocellular Carcinoma

Who this might be right for
Hepatocellular Carcinoma
Peking Union Medical College Hospital 24
Testing effectiveness (Phase 2)Active Not RecruitingNCT05462353
What this trial is testing

Study to Evaluate the Safety, Tolerability, and Efficacy of ASC41 Tablets in Adult Patients With NASH

Who this might be right for
Non-alcoholic Fatty Liver DiseaseNon-alcoholic Steatohepatitis
Gannex Pharma Co., Ltd. 183
Testing effectiveness (Phase 2)Looking for participantsNCT06429176
What this trial is testing

Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of SPL84 in Patients With Cystic Fibrosis

Who this might be right for
Cystic Fibrosis
SpliSense Ltd. 64
Testing effectiveness (Phase 2)Looking for participantsNCT07291076
What this trial is testing

Evaluate the Safety and Tolerability of Pumitamig Alone or In Combination With Ipilimumab in Participants With First-Line Advanced or Unresectable Hepatocellular Carcinoma (HCC) (ROSETTA HCC-206)

Who this might be right for
Hepatocellular Carcinoma (HCC)
Bristol-Myers Squibb 198
Next Page